CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

How Far We Have Come, How Far We Have Yet to Go in Atherosclerosis Research From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events Can Biomarkers of Myocardial Injury Provide Complementary Information to Coronary Imaging? Association of Sustained Blood Pressure Control with Multimorbidity Progression Among Older Adults Adenosine and adenosine receptor-mediated action in coronary microcirculation SR-B1 Drives Endothelial Cell LDL Transcytosis via DOCK4 to Promote Atherosclerosis Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease Risk: Clinical Perspectives and Basic Implications Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization

Consensus2019 Oct 15;74(15):1966-2011.

JOURNAL:J Am Coll Cardiol. Article Link

2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee

Hollenberg SM, Warner Stevenson L, Ahmad T Keywords: ACC Expert Consensus Decision Pathway; CHF; angiotensin receptor-neprilysin inhibitors; beta blockers; comorbidities; diuretics; guideline-directed medical therapy; heart failure

FULL TEXT PDF